analysed the serum lipid profile was altered in
patients with skin tags, mainly of LDL and total
cholesterol levels. This result was also supported
from a study conducted by Maluki AH and
Gorpelioglu C et al (Maluki et al, 2019; Gorpelioglu
et al, 2009). Abd Eldaiem et alfoundsignificant
different serum lipid profile in 60 patients with skin
tag in compare to the 60 control group (Eldaiem,
2016).
Another study by Wali V et alalso supported
a significant different serum lipid profile in 63
patients with skin tag in compare to the 60 control
group (Wali et al, 2016).
According to a study by Jusuf NK et al, there is
plausible mechanisms that explain pathogenesis of
skin tags in elevated fat mass caused increased level
of leptin. Abnormal serum lipid profile may cause
increase fat mass.The concentration of leptin is
correlated with fat mass, obesity individuals often
had elevated levels of leptin. Leptin is a growth
hormone that suggests active in the process of
proliferation and differentiation keratinocytes and
fibroblast (Jusuf et al, 2017). An in vivo study
showed that leptin has an ability to induce
proliferation of keratinocytes together with other
growth factor (Erkek et al, 2011).
The limitationof this study, leptin level was not
measured, the study was done in a single centre with
small sample size population. Future studies with
multi center and larger sample size population were
needed to further support the association serum lipid
profile with skin tag.
5 CONCLUSION
Abnormal serum lipid profile was found in almost
all patients with skin tag, mainly of LDL and total
cholesterol. Abnormal serum lipid profile in patients
with skin tag may associated with metabolic
syndrome. Life style modification of weight
reduction and alteration of dietary habits should be
encourage in patients with skin tag.
ACKNOWLEDGEMENT
The authors would like to thank the Department of
Dermatology and Venereology, and Faculty of
Medicine of Sriwijaya University and all those who
assist in the effort of this research.
REFERENCES
De, D., Biswas, M., Pal, D., Biswas, T., 2017. Can
acrochordons be a marker of metabolic syndrome?.
JEMDS, 6(56), pp. 4183-4187.
Eldaiem, R.A., 2016. Assessment of lipid profile among
patient with skin tags in Khartoum State-Sudan.
EJBPS, 3(8), pp. 45-48.
Erkek, E., Kisa, U., Bagci, Y., Sezikli, H., 2011. Leptin
resistance and genetic predisposition as potential
mechanisms in the development of skin tags. Hong
Kong Journal of Dermatology and Venereology 19,
pp. 108–114.
Gorpelioglu, C., Erdal, E., Ardicoglu, Y., Adam, B.,
Sarifakioglu, E., 2009. Serum leptin, atherogenic
lipids and glucose levels in patients with skin tags.
Indian Journal of Dermatology 54, pp. 20–22.
doi:10.4103/0019-5154.48980.
Idris, S., Sunitha, S., 2014. Assessment of BMI, Serum
Leptin Levels and Lipid Profile in Patients with Skin
Tags. Journal of clinical and diagnostic research
:
JCDR 8, CC01-3.
doi:10.7860/JCDR/2014/10350.4853.
Jusuf, N.K., Putra, I.B., Kartayana, J., 2017. The
correlation between body mass index with the
occurrence of skin tag. Macedonian Journal of
Medical Sciences 5, pp. 271–274.
doi:10.3889/oamjms.2017.061
Kutzner, H.H., Kamino, H., Reddy, V.B., Pui, J., 2018.
Fibrous and fibrohistiocytic proliferations of the skin
and tendons. In: Bolognia JL, Schaffer JV, Cerroni L,
editors. Dermatology. 4
th
ed. New York: Elsevier
Limited;. p.2068-2085.
Maluki, A.H., & Abdullah, A.A., 2016. Metabolic
associations with skin tags. International Journal of
Dermatology Clinical Research, 2(1), pp. 003-11.
Rasi, A., Faghihi, A., Rahmanzadeh, Y., Hassannejad, H.,
2014. A comparison study of lipid profile levels
between skin tags affected people and normal
population in Tehran, Iran. Advanced biomedical
research 3, pp. 109. doi:10.4103/2277-9175.129709.
Sari, R., Akman, A., Alpsoy, E., Balci, M.K., 2010. The
metabolic profile in patients with skin tags. Clinical
and experimental medicine 10, pp. 193–197.
doi:10.1007/s10238-009-0086-5.
Tamega, A. de A., Aranha, A.M.P., Guiotoku, M.M.,
Miot, L.D.B., Miot, H.A., 2010. [Association between
skin tags and insulin resistance]. Anais brasileiros de
dermatologia 85, pp. 25–31. doi:10.1590/S0365-
05962010000100003.
Thomas, V.D., Snavely, N.R., Lee, K.K., Swanson, N.A.,
2012. Dermal hypertrophies and benign
fibroblastic/myofibroblastic tumors. In: Goldsmith
LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ,
Wolff K, editors. Fitzpatrick’s Dermatology in
General Medicine. 8
th
ed. New York: The McGraw-
Hill Companies, Inc;. p.707-17.
Tosson, Z., Ibrahim, S.A., Kandil, A.H., Husam, M., 2013.
Relationship between skin tags , leptin hormone and